VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics Management Strategies and Risk Stratification in VTE

  • End date
    Jul 27, 2023
  • participants needed
  • sponsor
    Johannes Gutenberg University Mainz
Updated on 27 March 2021
venous thromboembolism
deep vein thrombosis
pulmonary embolism
venous thrombosis
deep venous thrombosis of lower extremity


Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed.

VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE).

The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.

Condition Pulmonary Disease, Lung Disease, Venous Thrombosis, Deep Vein Thrombosis, Venous Thrombosis, Venous Thromboembolism, Venous Thromboembolism, Pulmonary Embolism, Pulmonary Embolism, Thromboembolism, Thromboembolism, Thrombosis, Thrombosis, Blood Clots, Blood Clots, Lung Disease, Deep Vein Thrombosis, deep venous thrombosis of lower extremity, deep venous thrombosis, lung embolism
Clinical Study IdentifierNCT02156401
SponsorJohannes Gutenberg University Mainz
Last Modified on27 March 2021


Yes No Not Sure

Inclusion Criteria

Age 18 years and Informed written consent
Clinical condition
Cohort 1: Clinical suspicion of acute PE (with or without DVT)
Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE)
Cohort 3: Incidentally diagnosed VTE
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note